BLOG

Ansun Biopharma Takes Aim at COVID-19 with Experimental Influenza Treatment

San Diego-based Ansun Biopharma used its influenza research data to dive into attempts to develop a treatment for COVID-19 using an investigational nebulized enzyme asset as a potential treatment for severely infected patients.